Skip to content

Efficacy of Sapylin in Reducing Postoperative Drainage Volume During Endoscopic Radical Thyroidectomy for Thyroid Cancer

Efficacy of Sapylin in Reducing Postoperative Drainage Volume During Endoscopic Radical Thyroidectomy for Thyroid Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103444
Enrollment
Unknown
Registered
2025-05-29
Start date
2024-03-02
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Treatment group:In the treatment group, prior to incision closure, Sapylin 10 KE was mixed with 20 mL of normal saline and injected into the thyroid surgical field via the drainage tube. The drainage
Control group:In the treatment group, prior to incision closure, Sapylin 10 KE was mixed with 20 mL of normal saline and injected into the thyroid surgical field via the drainage tube. The drainage tu

Sponsors

The Second Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The age of the patient is between 20 and 70 years old; 2. The tumor has no infiltration of perithyroid organs and no metastasis of distant organs; 3. Before surgery, laryngoscopy showed normal vocal cord function; 4. No significant abnormal laboratory test results before surgery; 5. Postoperative pathology is papillary thyroid carcinoma.TC.

Exclusion criteria

Exclusion criteria: 1. Patients with positive penicillin skin test; 2. Have coagulation disorders or anticoagulation therapy; 3. Uncontrolled diabetes mellitus or hypertension; 4. History of previous thyroid surgery; 5. Second operation due to postoperative complications such as bleeding and infection; 6. Obesity (body mass index > 35 kg/m^2); 7. Failure to sign informed consent; 8. Open surgery or intraoperative transfer to open surgery.

Design outcomes

Primary

MeasureTime frame
Drain amount (postoperative day 1);Drain amount (postoperative day 2);Drain amount (postoperative day 3);Drain amount (total);Day of drain remova;

Secondary

MeasureTime frame
White blood cell(WBC);Neutrophilic granulocyte (NEUT%);C-reactive protein(CRP);Seroma;Neck stiffness;Xerostomia;Dysphagia;Hoarseness ;Dysphonia;Globus sensation;Scar discomfort;Cold intolerance;Heat intolerance;Hot flushes;Myalgia;Feet or hands numbness;Muscle spasm;Sluggish movement;Weight gain;Dry eyes;Pruritus;Palpitations;Headache;Fatigue;Difficulty thinking clearly;Difficulty concentrating;Irritability;Anxiety;Sexual disinterest;

Countries

China

Contacts

Public ContactJun Huang

The Second Affiliated Hospital of Guangxi Medical University

hj2911@163.com+86 181 7410 0351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026